ovarian carcinoma

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients

Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients

May 19, 2017
 |  No Comments
 |  Drug Discovery

Treosulfan is an alkylating agent that is structurally related to busulfan. It is used in the treatment of ovarian carcinoma and currently considered in clinical trials as a conditioning agent prior to autologous […]